Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-22-063943

Director acquired 29,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shizuru Judith Anne · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-12 Grant or award : show line 1 in the form +29,500 1,159,012 D
Loading xslF345X03/ownership.xml…